Fate Therapeutics, Inc. (NASDAQ:FATE) Shares Purchased by Wells Fargo & Company MN
Wells Fargo & Company MN boosted its position in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 56.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 92,395 shares of the biopharmaceutical company’s stock after purchasing an additional […]
Wells Fargo & Company MN boosted its position in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 56.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 92,395 shares of the biopharmaceutical company’s stock after purchasing an additional […]
